Report Detail
Global (United States, European Union and China) Angiopoietin 2 Market Research Report 2019-2025
- RnM3364238 |
- 01 July, 2020 |
- Global |
- 115 Pages |
- QYResearch |
- Pharma & Healthcare
Angiopoietin 2 market is segmented by Type, and by Application. Players, stakeholders, and other participants in the global Angiopoietin 2 market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on sales, revenue and forecast by Type and by Application for the period 2015-2026.
Segment by Type, the Angiopoietin 2 market is segmented into
Atu-111
BI-836880
LY-3127804
MEDI-3617
Others
Segment by Application, the Angiopoietin 2 market is segmented into
Hospital
Clinic
Others
Regional and Country-level Analysis
The Angiopoietin 2 market is analysed and market size information is provided by regions (countries).
The key regions covered in the Angiopoietin 2 market report are North America, Europe, Asia Pacific, Latin America, Middle East and Africa. It also covers key regions (countries), viz, U.S., Canada, Germany, France, U.K., Italy, Russia, China, Japan, South Korea, India, Australia, Taiwan, Indonesia, Thailand, Malaysia, Philippines, Vietnam, Mexico, Brazil, Turkey, Saudi Arabia, U.A.E, etc.
The report includes country-wise and region-wise market size for the period 2015-2026. It also includes market size and forecast by Type, and by Application segment in terms of sales and revenue for the period 2015-2026.
Competitive Landscape and Angiopoietin 2 Market Share Analysis
Angiopoietin 2 market competitive landscape provides details and data information by players. The report offers comprehensive analysis and accurate statistics on revenue by the player for the period 2015-2020. It also offers detailed analysis supported by reliable statistics on revenue (global and regional level) by players for the period 2015-2020. Details included are company description, major business, company total revenue and the sales, revenue generated in Angiopoietin 2 business, the date to enter into the Angiopoietin 2 market, Angiopoietin 2 product introduction, recent developments, etc.
The major vendors covered:
Amgen Inc.
AnGes MG, Inc.
Boehringer Ingelheim GmbH
Eli Lilly and Company
F. Hoffmann-La Roche Ltd.
MedImmune, LLC
Regeneron Pharmaceuticals, Inc.
RXi Pharmaceuticals Corporation
Silence Therapeutics Plc
Synergys Biotherapeutics, Inc.
1 Study Coverage
- 1.1 Angiopoietin 2 Product Introduction
- 1.2 Market Segments
- 1.3 Key Angiopoietin 2 Manufacturers Covered: Ranking by Revenue
- 1.4 Market by Type
- 1.4.1 Global Angiopoietin 2 Market Size Growth Rate by Type
- 1.4.2 Atu-111
- 1.4.3 BI-836880
- 1.4.4 LY-3127804
- 1.4.5 MEDI-3617
- 1.4.6 Others
- 1.5 Market by Application
- 1.5.1 Global Angiopoietin 2 Market Size Growth Rate by Application
- 1.5.2 Hospital
- 1.5.3 Clinic
- 1.5.4 Others
- 1.6 Study Objectives
- 1.7 Years Considered
2 Executive Summary
- 2.1 Global Angiopoietin 2 Market Size, Estimates and Forecasts
- 2.1.1 Global Angiopoietin 2 Revenue 2015-2026
- 2.1.2 Global Angiopoietin 2 Sales 2015-2026
- 2.2 Global Angiopoietin 2, Market Size by Producing Regions: 2015 VS 2020 VS 2026
- 2.2.1 Global Angiopoietin 2 Retrospective Market Scenario in Sales by Region: 2015-2020
- 2.2.2 Global Angiopoietin 2 Retrospective Market Scenario in Revenue by Region: 2015-2020
3 Global Angiopoietin 2 Competitor Landscape by Players
- 3.1 Angiopoietin 2 Sales by Manufacturers
- 3.1.1 Angiopoietin 2 Sales by Manufacturers (2015-2020)
- 3.1.2 Angiopoietin 2 Sales Market Share by Manufacturers (2015-2020)
- 3.2 Angiopoietin 2 Revenue by Manufacturers
- 3.2.1 Angiopoietin 2 Revenue by Manufacturers (2015-2020)
- 3.2.2 Angiopoietin 2 Revenue Share by Manufacturers (2015-2020)
- 3.2.3 Global Angiopoietin 2 Market Concentration Ratio (CR5 and HHI) (2015-2020)
- 3.2.4 Global Top 10 and Top 5 Companies by Angiopoietin 2 Revenue in 2019
- 3.2.5 Global Angiopoietin 2 Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
- 3.3 Angiopoietin 2 Price by Manufacturers
- 3.4 Angiopoietin 2 Manufacturing Base Distribution, Product Types
- 3.4.1 Angiopoietin 2 Manufacturers Manufacturing Base Distribution, Headquarters
- 3.4.2 Manufacturers Angiopoietin 2 Product Type
- 3.4.3 Date of International Manufacturers Enter into Angiopoietin 2 Market
- 3.5 Manufacturers Mergers & Acquisitions, Expansion Plans
4 Market Size by Type (2015-2026)
- 4.1 Global Angiopoietin 2 Market Size by Type (2015-2020)
- 4.1.1 Global Angiopoietin 2 Sales by Type (2015-2020)
- 4.1.2 Global Angiopoietin 2 Revenue by Type (2015-2020)
- 4.1.3 Angiopoietin 2 Average Selling Price (ASP) by Type (2015-2026)
- 4.2 Global Angiopoietin 2 Market Size Forecast by Type (2021-2026)
- 4.2.1 Global Angiopoietin 2 Sales Forecast by Type (2021-2026)
- 4.2.2 Global Angiopoietin 2 Revenue Forecast by Type (2021-2026)
- 4.2.3 Angiopoietin 2 Average Selling Price (ASP) Forecast by Type (2021-2026)
- 4.3 Global Angiopoietin 2 Market Share by Price Tier (2015-2020): Low-End, Mid-Range and High-End
5 Market Size by Application (2015-2026)
- 5.1 Global Angiopoietin 2 Market Size by Application (2015-2020)
- 5.1.1 Global Angiopoietin 2 Sales by Application (2015-2020)
- 5.1.2 Global Angiopoietin 2 Revenue by Application (2015-2020)
- 5.1.3 Angiopoietin 2 Price by Application (2015-2020)
- 5.2 Angiopoietin 2 Market Size Forecast by Application (2021-2026)
- 5.2.1 Global Angiopoietin 2 Sales Forecast by Application (2021-2026)
- 5.2.2 Global Angiopoietin 2 Revenue Forecast by Application (2021-2026)
- 5.2.3 Global Angiopoietin 2 Price Forecast by Application (2021-2026)
6 North America
- 6.1 North America Angiopoietin 2 by Country
- 6.1.1 North America Angiopoietin 2 Sales by Country
- 6.1.2 North America Angiopoietin 2 Revenue by Country
- 6.1.3 U.S.
- 6.1.4 Canada
- 6.2 North America Angiopoietin 2 Market Facts & Figures by Type
- 6.3 North America Angiopoietin 2 Market Facts & Figures by Application
7 Europe
- 7.1 Europe Angiopoietin 2 by Country
- 7.1.1 Europe Angiopoietin 2 Sales by Country
- 7.1.2 Europe Angiopoietin 2 Revenue by Country
- 7.1.3 Germany
- 7.1.4 France
- 7.1.5 U.K.
- 7.1.6 Italy
- 7.1.7 Russia
- 7.2 Europe Angiopoietin 2 Market Facts & Figures by Type
- 7.3 Europe Angiopoietin 2 Market Facts & Figures by Application
8 Asia Pacific
- 8.1 Asia Pacific Angiopoietin 2 by Region
- 8.1.1 Asia Pacific Angiopoietin 2 Sales by Region
- 8.1.2 Asia Pacific Angiopoietin 2 Revenue by Region
- 8.1.3 China
- 8.1.4 Japan
- 8.1.5 South Korea
- 8.1.6 India
- 8.1.7 Australia
- 8.1.8 Taiwan
- 8.1.9 Indonesia
- 8.1.10 Thailand
- 8.1.11 Malaysia
- 8.1.12 Philippines
- 8.1.13 Vietnam
- 8.2 Asia Pacific Angiopoietin 2 Market Facts & Figures by Type
- 8.3 Asia Pacific Angiopoietin 2 Market Facts & Figures by Application
9 Latin America
- 9.1 Latin America Angiopoietin 2 by Country
- 9.1.1 Latin America Angiopoietin 2 Sales by Country
- 9.1.2 Latin America Angiopoietin 2 Revenue by Country
- 9.1.3 Mexico
- 9.1.4 Brazil
- 9.1.5 Argentina
- 9.2 Central & South America Angiopoietin 2 Market Facts & Figures by Type
- 9.3 Central & South America Angiopoietin 2 Market Facts & Figures by Application
10 Middle East and Africa
- 10.1 Middle East and Africa Angiopoietin 2 by Country
- 10.1.1 Middle East and Africa Angiopoietin 2 Sales by Country
- 10.1.2 Middle East and Africa Angiopoietin 2 Revenue by Country
- 10.1.3 Turkey
- 10.1.4 Saudi Arabia
- 10.1.5 U.A.E
- 10.2 Middle East and Africa Angiopoietin 2 Market Facts & Figures by Type
- 10.3 Middle East and Africa Angiopoietin 2 Market Facts & Figures by Application
11 Company Profiles
- 11.1 Amgen Inc.
- 11.1.1 Amgen Inc. Corporation Information
- 11.1.2 Amgen Inc. Description and Business Overview
- 11.1.3 Amgen Inc. Sales, Revenue and Gross Margin (2015-2020)
- 11.1.4 Amgen Inc. Angiopoietin 2 Products Offered
- 11.1.5 Amgen Inc. Related Developments
- 11.2 AnGes MG, Inc.
- 11.2.1 AnGes MG, Inc. Corporation Information
- 11.2.2 AnGes MG, Inc. Description and Business Overview
- 11.2.3 AnGes MG, Inc. Sales, Revenue and Gross Margin (2015-2020)
- 11.2.4 AnGes MG, Inc. Angiopoietin 2 Products Offered
- 11.2.5 AnGes MG, Inc. Related Developments
- 11.3 Boehringer Ingelheim GmbH
- 11.3.1 Boehringer Ingelheim GmbH Corporation Information
- 11.3.2 Boehringer Ingelheim GmbH Description and Business Overview
- 11.3.3 Boehringer Ingelheim GmbH Sales, Revenue and Gross Margin (2015-2020)
- 11.3.4 Boehringer Ingelheim GmbH Angiopoietin 2 Products Offered
- 11.3.5 Boehringer Ingelheim GmbH Related Developments
- 11.4 Eli Lilly and Company
- 11.4.1 Eli Lilly and Company Corporation Information
- 11.4.2 Eli Lilly and Company Description and Business Overview
- 11.4.3 Eli Lilly and Company Sales, Revenue and Gross Margin (2015-2020)
- 11.4.4 Eli Lilly and Company Angiopoietin 2 Products Offered
- 11.4.5 Eli Lilly and Company Related Developments
- 11.5 F. Hoffmann-La Roche Ltd.
- 11.5.1 F. Hoffmann-La Roche Ltd. Corporation Information
- 11.5.2 F. Hoffmann-La Roche Ltd. Description and Business Overview
- 11.5.3 F. Hoffmann-La Roche Ltd. Sales, Revenue and Gross Margin (2015-2020)
- 11.5.4 F. Hoffmann-La Roche Ltd. Angiopoietin 2 Products Offered
- 11.5.5 F. Hoffmann-La Roche Ltd. Related Developments
- 11.6 MedImmune, LLC
- 11.6.1 MedImmune, LLC Corporation Information
- 11.6.2 MedImmune, LLC Description and Business Overview
- 11.6.3 MedImmune, LLC Sales, Revenue and Gross Margin (2015-2020)
- 11.6.4 MedImmune, LLC Angiopoietin 2 Products Offered
- 11.6.5 MedImmune, LLC Related Developments
- 11.7 Regeneron Pharmaceuticals, Inc.
- 11.7.1 Regeneron Pharmaceuticals, Inc. Corporation Information
- 11.7.2 Regeneron Pharmaceuticals, Inc. Description and Business Overview
- 11.7.3 Regeneron Pharmaceuticals, Inc. Sales, Revenue and Gross Margin (2015-2020)
- 11.7.4 Regeneron Pharmaceuticals, Inc. Angiopoietin 2 Products Offered
- 11.7.5 Regeneron Pharmaceuticals, Inc. Related Developments
- 11.8 RXi Pharmaceuticals Corporation
- 11.8.1 RXi Pharmaceuticals Corporation Corporation Information
- 11.8.2 RXi Pharmaceuticals Corporation Description and Business Overview
- 11.8.3 RXi Pharmaceuticals Corporation Sales, Revenue and Gross Margin (2015-2020)
- 11.8.4 RXi Pharmaceuticals Corporation Angiopoietin 2 Products Offered
- 11.8.5 RXi Pharmaceuticals Corporation Related Developments
- 11.9 Silence Therapeutics Plc
- 11.9.1 Silence Therapeutics Plc Corporation Information
- 11.9.2 Silence Therapeutics Plc Description and Business Overview
- 11.9.3 Silence Therapeutics Plc Sales, Revenue and Gross Margin (2015-2020)
- 11.9.4 Silence Therapeutics Plc Angiopoietin 2 Products Offered
- 11.9.5 Silence Therapeutics Plc Related Developments
- 11.10 Synergys Biotherapeutics, Inc.
- 11.10.1 Synergys Biotherapeutics, Inc. Corporation Information
- 11.10.2 Synergys Biotherapeutics, Inc. Description and Business Overview
- 11.10.3 Synergys Biotherapeutics, Inc. Sales, Revenue and Gross Margin (2015-2020)
- 11.10.4 Synergys Biotherapeutics, Inc. Angiopoietin 2 Products Offered
- 11.10.5 Synergys Biotherapeutics, Inc. Related Developments
- 11.1 Amgen Inc.
- 11.1.1 Amgen Inc. Corporation Information
- 11.1.2 Amgen Inc. Description and Business Overview
- 11.1.3 Amgen Inc. Sales, Revenue and Gross Margin (2015-2020)
- 11.1.4 Amgen Inc. Angiopoietin 2 Products Offered
- 11.1.5 Amgen Inc. Related Developments
12 Future Forecast by Regions (Countries) (2021-2026)
- 12.1 Angiopoietin 2 Market Estimates and Projections by Region
- 12.1.1 Global Angiopoietin 2 Sales Forecast by Regions 2021-2026
- 12.1.2 Global Angiopoietin 2 Revenue Forecast by Regions 2021-2026
- 12.2 North America Angiopoietin 2 Market Size Forecast (2021-2026)
- 12.2.1 North America: Angiopoietin 2 Sales Forecast (2021-2026)
- 12.2.2 North America: Angiopoietin 2 Revenue Forecast (2021-2026)
- 12.2.3 North America: Angiopoietin 2 Market Size Forecast by Country (2021-2026)
- 12.3 Europe Angiopoietin 2 Market Size Forecast (2021-2026)
- 12.3.1 Europe: Angiopoietin 2 Sales Forecast (2021-2026)
- 12.3.2 Europe: Angiopoietin 2 Revenue Forecast (2021-2026)
- 12.3.3 Europe: Angiopoietin 2 Market Size Forecast by Country (2021-2026)
- 12.4 Asia Pacific Angiopoietin 2 Market Size Forecast (2021-2026)
- 12.4.1 Asia Pacific: Angiopoietin 2 Sales Forecast (2021-2026)
- 12.4.2 Asia Pacific: Angiopoietin 2 Revenue Forecast (2021-2026)
- 12.4.3 Asia Pacific: Angiopoietin 2 Market Size Forecast by Region (2021-2026)
- 12.5 Latin America Angiopoietin 2 Market Size Forecast (2021-2026)
- 12.5.1 Latin America: Angiopoietin 2 Sales Forecast (2021-2026)
- 12.5.2 Latin America: Angiopoietin 2 Revenue Forecast (2021-2026)
- 12.5.3 Latin America: Angiopoietin 2 Market Size Forecast by Country (2021-2026)
- 12.6 Middle East and Africa Angiopoietin 2 Market Size Forecast (2021-2026)
- 12.6.1 Middle East and Africa: Angiopoietin 2 Sales Forecast (2021-2026)
- 12.6.2 Middle East and Africa: Angiopoietin 2 Revenue Forecast (2021-2026)
- 12.6.3 Middle East and Africa: Angiopoietin 2 Market Size Forecast by Country (2021-2026)
13 Market Opportunities, Challenges, Risks and Influences Factors Analysis
- 13.1 Market Opportunities and Drivers
- 13.2 Market Challenges
- 13.3 Market Risks/Restraints
- 13.4 Porter's Five Forces Analysis
- 13.5 Primary Interviews with Key Angiopoietin 2 Players (Opinion Leaders)
14 Value Chain and Sales Channels Analysis
- 14.1 Value Chain Analysis
- 14.2 Angiopoietin 2 Customers
- 14.3 Sales Channels Analysis
- 14.3.1 Sales Channels
- 14.3.2 Distributors
15 Research Findings and Conclusion
16 Appendix
- 16.1 Research Methodology
- 16.1.1 Methodology/Research Approach
- 16.1.2 Data Source
- 16.2 Author Details
Summary:
Get latest Market Research Reports on Angiopoietin 2. Industry analysis & Market Report on Angiopoietin 2 is a syndicated market report, published as Global (United States, European Union and China) Angiopoietin 2 Market Research Report 2019-2025. It is complete Research Study and Industry Analysis of Angiopoietin 2 market, to understand, Market Demand, Growth, trends analysis and Factor Influencing market.
REPORT YOU MIGHT BE INTERESTED
Related Reports
Reason to Buy
Reports and Markets
Contact Us
+1-352-353-0818 (US)Newsletter
KEEP UP TO DATE ON ALL THE LATEST REPORTS
